Mirum Pharmaceuticals宣布完成总额6亿美元的可转换优先票据发行的定价工作。与此同时,公司计划将此次发行所得款项的一部分,用于赎回其2029年到期的部分可转换票据,以实现债务结构的优化。
Mirum Pharmaceuticals宣布完成总额6亿美元的可转换优先票据发行的定价工作。与此同时,公司计划将此次发行所得款项的一部分,用于赎回其2029年到期的部分可转换票据,以实现债务结构的优化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.